PTD-DBM

PTD-DBM, short for Protein Transduction Domain-fused Dishevelled Binding Motif, is a groundbreaking peptide-based treatment for hair loss. Developed by Professor Kang-Yell Choi and his team at Yonsei University in South Korea, PTD-DBM targets the CXXC-type zinc finger protein 5 (CXXC5), a negative regulator of the Wnt/β-catenin pathway, which is crucial for hair regeneration and wound healing. By interfering with the binding of CXXC5 to the Dishevelled (Dvl) protein, PTD-DBM promotes the formation of new hair follicles and prevents hair loss. This peptide has shown remarkable efficacy in laboratory mice, leading to significant hair regrowth and even wound-induced hair neogenesis when combined with valproic acid (VPA), an activator of the Wnt/β-catenin pathway.

The discovery of PTD-DBM represents a significant advancement in the field of hair loss treatment, offering hope to millions of people worldwide. Its mechanism of action, targeting a specific protein pathway, sets it apart from traditional treatments and underscores the potential of peptide-based therapies in addressing complex biological processes. As research continues, PTD-DBM holds promise for not only transforming the landscape of hair loss treatment but also opening new avenues for wound healing and regenerative medicine.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

https://en.wikipedia.org/wiki/PTD-DBM
https://www.novoprolabs.com/p/ptd-dbm-318831.html
https://suaway.com/en/home/349-ptd-dbm-30-ml-1-mg.html